A Study to Evaluate the Effect of ASP1941 in Combination With Metformin in Adult Patients With Type 2 Diabetes Mellitus

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 343 participants.

Also called NCT01117584

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 343 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01117584
  • EudraCT 2009-013881-25
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
United States, Hungary, Italy, Poland, Romania, United Kingdom (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01117584. Randomized; quadruple masking; primary purpose treatment. Start 2010-04-06 (actual); primary completion 2011-04-01 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Study to Evaluate the Effect of ASP1941 in Combination With Metformin in Adult Patients With Type 2 Diabetes Mellitus
Acronym
BALANCE
Condition
Type 2 Diabetes Mellitus
Intervention (Drug)
ipragliflozin
Intervention (Drug)
Placebo
Intervention (Drug)
Metformin
Lead sponsor
Astellas Pharma Inc (class: industry)

Record details

Record id
cardio:ct-nct01117584
Content hash
53dd3cb967fcd6fe43767837a53ab5a3a5fc20d35143ae939c72839caf92460d